Short Interest in Clearmind Medicine Inc. (NASDAQ:CMND) Declines By 40.7%

Clearmind Medicine Inc. (NASDAQ:CMND) saw a significant decrease in short interest in November. As of November 15th, there was short interest totalling 187,600 shares, a decrease of 40.7% from the October 31st total of 316,600 shares. Currently, 6.2% of the shares of the company are sold short. Based on an average daily volume of 258,000 shares, the days-to-cover ratio is presently 0.7 days.

Clearmind Medicine Stock Performance

Shares of NASDAQ:CMND traded down $0.05 during trading on Thursday, reaching $1.28. The company had a trading volume of 61,198 shares, compared to its average volume of 1,313,104. Clearmind Medicine has a twelve month low of $0.92 and a twelve month high of $6.80. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 0.01. The firm’s fifty day moving average is $1.37 and its 200 day moving average is $1.36.

Clearmind Medicine (NASDAQ:CMND) last issued its quarterly earnings results on Monday, September 16th. The company reported ($0.59) earnings per share (EPS) for the quarter.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Clearmind Medicine stock. AdvisorShares Investments LLC grew its holdings in shares of Clearmind Medicine Inc. (NASDAQ:CMND) by 14.2% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 128,641 shares of the company’s stock after purchasing an additional 15,948 shares during the period. AdvisorShares Investments LLC owned approximately 7.60% of Clearmind Medicine worth $214,000 as of its most recent filing with the Securities and Exchange Commission. Institutional investors own 96.05% of the company’s stock.

About Clearmind Medicine

Clearmind Medicine Inc, a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors.